Dr. Eric K. Singhi discusses the significance of the FDA approval of subcutaneous Opdivo for patients with solid tumors.

KTVZ News has an update Friday on our previous reports about the sometimes tragic results from use of Librela, a once-monthly ...

Real Housewives of New York City” star Bethenny Frankel shed light on Hollywood’s wonky perception of the term “sobriety,” ...

Botox and dermal fillers are popular treatments commonly used for cosmetic purposes. While both help reduce wrinkles, they do ...

An honest review of the new Miria laser, a non-ablative treatment safe for all skin tones that tightens while diminishing ...

Experts shared diagnosis and management strategies for chronic pruritus at the Dermatology Days of Paris 2024 conference.

Manufacturers increasingly but still infrequently follow Food and Drug Administration guidance that recommends testing pulse oximeters on participants with a range of skin pigmentations, according to ...

There’s no question “clean beauty” is in, and hopefully it’s here to stay. But some needs for the condition or appearance of ...

In a world where aging gracefully is the ultimate goal for many, the quest for effective anti-aging solutions has led to ...

Federal health officials are proposing changes to make sure medical devices that measure oxygen levels are working for ...

Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for ...

The agency is proposing that device manufacturers improve their testing to including larger, more diverse sample sizes.